Prostate Restored
Photo: Jacob Morch
Brain metastases, a specific form of Stage IV melanoma, are one of the most common and difficult-to-treat complications of melanoma. Brain metastases differ from all other metastases in terms of risk factors, diagnosis, and treatment.
To get the best health benefits, be sure to choose 100% organic water-based cranberry juice. So how does cranberry juice help? It can prevent...
Read More »
In humans, consuming cocoa is associated with a reduction in blood pressure (in healthy people and those with high blood pressure). This lowering...
Read More »
Onions and garlic may enhance testosterone production in a variety of potential ways. Garlic and onions contain diallyl disulfide, a chemical that...
Read More »
Some cancers are difficult to treat and have high rates of recurrence. Glioblastoma, for example, recurs in nearly all patients, despite treatment....
Read More »WBRT has a significant risk of causing damage to normal brain tissue, resulting in neurocognitive decline. New techniques (hippocampal sparing RT) and medications (memantine) are often used to reduce the impact of WBRT on cognitive function.
We can't correct our vision without professional help, and there's no quick-and-easy fix for eyesight problems. But with tools such as good...
Read More »
Hero Pose (Virasana) The Hero Pose is another seated position that can help release pelvic tension around the prostate. To do this pose, an...
Read More »
Fluxactive Complete is conveniently packed with over 14 essential prostate powerhouse herbs, vitamins and grade A nutrients which work synergistically to help you support a healthy prostate faster
Learn More »There are multiple FDA-approved targeted therapies for patients with metastatic melanoma with a BRAF mutation in their tumor. Standard of care targeted therapy regimens for such patients include combined treatment with a BRAF inhibitor and a MEK inhibitor. The three approved combination regimens are Tafinlar (dabrafenib) and Mekinist (trametinib); Zelboraf (vemurafenib) and Cotellic (cobimetinib); and Braftovi (encorafenib) and Mektovi (binimetinib). These treatments are NOT to be used in patients who do not have a BRAF mutation in their tumor. In a phase II clinical trial of Tafinlar and Mekinist in melanoma patients with new or growing brain metastases, more than 50% of patients showed significant shrinkage of their brain metastases, and approximately 80% of patients achieved at least slowing of tumor growth. The treatment can be used and be effective in patients who need to take steroids to control brain swelling and/or symptoms from their brain metastases. Although initially effective in most patients, data from clinical trials suggest that the response to targeted therapy in the brain is less durable (long lasting) than the response to targeted therapy in tumors in other parts of the body.
They have ligaments and connective tissue. When the gravity pulls the breasts down, those ligaments and the skin can stretch, and so the breast...
Read More »
It also suggests that people should not exceed 10 days of sexual abstinence. A 2018 study suggests that ejaculatory abstinence periods of more than...
Read More »
Anti-inflammatory golden milk is your bedtime go-to Initial mice studies have found that turmeric can protect against oxidative damage and sleep...
Read More »
13 foods that help lower blood pressure romaine lettuce. arugula. kale. turnip greens. collard greens. spinach. beet greens. Swiss chard.
Read More »